Cervical Cancer Awareness

HPV is so common in the United States that nearly all men and women will contract the virus at some point during life (Center for Disease Control and Prevention [CDC], 2017). In the United States, in 2008, it is reported that 3.2 million, or one in four adolescent women, ages 14 to 19 have had or have an STD (Kostas-Polston et al., 2012). The rate of HPV cases has only increased since 2008. The prevalence of a genital infection with any HPV type was 42.5% among United States during 2013–2014 (CDC, 2017). The incidence of HPV in the United States is about 14 million people each year.

The incidence of Human Papillomavirus (HPV) in my local community Lockport, Illinois is one out of every five people have HPV and due to the vaccinations to prevent HPV, Illinois ranks 48th among the United States for incidences of HPV (Manchir, 2013). HPV is a sexually transmitted infection that is transmitted through sexual contact. HPV is transmitted during vaginal, oral, or anal sex and on rare occasions, through birth during delivery (Illinois Department of Public Health [IDPH], 2013). Surprisingly, 50 percent of men and women that are active sexually will acquire HPV during their lifetime! HPV has affected 20 million Americans and an astounding, six million additional people will become infected every year (Illinois Department of Public Health [IDPH], 2013). Although Lockport Illinois has a lower amount of people with HPV, as a public health nurse, I realize this is an issue that needs to be addressed in my local community. Awareness is the key to prevention. Teenagers, parents, and all adults need to

Primarily, cancer of the cervix uteri is affecting women in developing countries such as “sub-Saharan Africa, Melanesia, Latin America and the Caribbean, South-Central Asia, and South East Asia” (Parkin and Maxwell, 2006, p. 1). Given the incidence rates of the different ethnicities aforementioned by the USCSWG, there is no plausible evidence that negates a positive correlation of cervical cancer among racial ethnicities of divergent countries to the United States. To exemplify, Parkin and Maxwell (2006) suggest that the standard age incidence rate (ASR) for cervical cancer in the Caribbean is 33.5 per 100,000, the ASR for sub-Saharan Africa is 31.0 per 100,000, and the ASR for the United States is less than 15.0 per 100,000. Hariri, Unger, Sternberg, Dunne, Swan, Patel, and Markowitz (2011) remark that the prevalence of HPV in Africa-American women was high, even with just having one lifetime partner.

The symptoms of cervical cancer are not always obvious thus the introduction of NHS cervical screening programme. The aim of the NHS Cervical Screening Programme is prevent the number women who die from cervical cancer each year due to not having early diagnoses. Since the introduction of the programme, a report was done between the NHS Cervical Screening Programme and Trent Cancer Registry it found that “Incidence and mortality rates in England have fallen considerably over the past 20 years. During this period, incidence rates decreased by over a third and mortality rates reduced by 60%. Survival, following a diagnosis of cervical cancer has improved in England since the 1980’s from the 83% to 88%”. (NHS, 2012, pp. P10-11).

HPV vaccination is the most common used method for preventing cervical cancer in young girls ranging from age nine to eleven years old. The overall perception of the vaccine is positive by the public because of its wide use and support by state laws, school systems and medical associations. According to the American Pediatric Association the vaccine has an excellent safety record. (Nirvi,1) A reasonable amount of parents still feel skeptical about mandatory HPV vaccination on their kids and lack great knowledge regarding the vaccine’s effectiveness.

Schmidt and Parsons investigated the trends of HPV vaccination, interests, and reasons for non-vaccination in young adult women. Results of testing showed that women who had received one or more doses of the vaccine were more likely to be between the ages of 18-21, to be non-hispanic white, to have private health insurance and a usual source of care that has not been delayed, and to have more than a high-school education. Among women 18-26 years of age, the HPV vaccine uptake increased from 11.6% in 2008 to 34.1% in 2012. In 2008 and

HPV and its associated diseases affect men and women of all races and ethnicities. In the United States, Caucasian females have a lower incidence of cervical cancer and a higher incidence of vulvar cancer, while vaginal cancers associated with HPV occur more frequently in black females CITE JEMAL 2013 HPV linked oropharyngeal cancers are increasing in both sexes across all ethnicities with the exception of blacks, and hpv associated anal cancers have increased in both males and females of all races and ethnicities CITE JEMAL 2013

The discussion section reiterates the primary purpose of this article. However, it also overlooks key data in the discussion and results sections. The prime focus is on how successful they have speculated the outcomes of the parental attitudes towards using the HPV information and the HPV vaccine. Again claiming that those in the intervention group who received the additional information reported a statistically significant increase and their perceived benefit repeatedly laid out in survey gaining 43% more likely to accept the HPV vaccine. However, more data is revealed in the descriptive and qualitative feedback section. Consequently, while the purpose is stated, generally did not determine value of the tested

Human papillomavirus (HPV) is the most common sexually transmitted disease (STD) and can affect many sexually active individuals throughout their lifetimes and is spread through anal, oral and vaginal sex (CDC, 2016). HPV currently affects 79 million Americans with 14 million new cases of infection every year and is so pervasive most sexually-active individuals will encounter some form of the virus during their lives (CDC, 2016). HPV can be troublesome to detect as symptoms can develop years after initial infection or may not be seen at all, but in many cases HPV does not cause lasting health problems (CDC, 2016).

Cervical cancer is one of the highly popular disease for the women. Different programmes has been made up to fight against this deadly disease. New Zealand has one of the best screening programmes in the world. The establishment of National Cervical Cancer Screening Programme in NZ in 1990 had reduced a significant number of 60% of women who develop cervical cancer and who die from it since it was built. More than 1 million New Zealander women are enrolled in this programme and 95 % are eligible. The Cervical Cancer screening programme aims to; informing women about the importance of having the cervical screening tests; promoting cervical screening tests on a regular basis to women aged 20–70; ensuring high-quality and culturally appropriate services; supporting women with abnormal tests; ensuring there is regular monitoring to see that the goals of the programme are being met. The NCSP also acknowledges the importance of the Treaty of Waitangi in providing a screening programme that is successful for all New Zealand women.

Among the many arguments for mandatory HPV vaccination, the foremost is that it is an important medical achievement and a major public health milestone. This vaccine has proven to be one-hundred percent effective in preventing the 4 HPV strains that are responsible for seventy percent of cervical cancers and ninety percent of genital warts. In addition, no serious side effects have been identified. Because this vaccine is a preventive measure, administration before onset of sexual activity is ideal; however, even females who have been sexually active can still benefit from this vaccination (Perkins et al., 2010). Nationally and internationally, the HPV vaccine will significantly reduce disease burden by reducing monetary and psychological costs of invasive procedures that remove precancerous and cancerous lesions. By combining vaccination with routine Pap smear screening, these public health efforts have the remarkable opportunity to eradicate cervical cancer (Ramet et al., 2011).

Human papillomavirus, commonly abbreviated as HPV, is the most common sexually transmitted virus that can cause a variety of diseases. It is transferred from person to person by either genital contact or from oral contact. Most men and women who are sexually active will be infected with this virus at least once in their life (“HPV”). A reason why HPV has become such a big problem in society is because of the fact that it is a virus, and thus cannot be treated with antibiotics. For other viral infections, it is possible to wait for the body’s immune system to rid the body of the foreign invader, but HPV is a virus that can cause more serious health problems such as genital warts, cancers of the mouth, anus, or vagina, as well as the cervix. Another reason why this problem exists in society may be due to more relaxed standards regarding sexual activity. In today’s society, people are more likely to have more than one sexual partner, making it easier for the virus to spread within the population. People are also becoming sexually active at younger ages before they receive education about safe sex at school or at home, which is also a factor in the spread of HPV in the population. Most people do not exhibit negative symptoms from the virus; indeed, some of them may not even know they have contracted it, for the body can clear out the virus on its own ninety percent of the time (“What is HPV?” 2013). HPV

A sexually transmitted agent, human papillomavirus (HPV) is the causative agent for genital warts and most invasive forms of cervical cancer and other cancers of the anogenital tract (Trottier & Franco, 2006). In the United States (US), about 80 million people are infected with at least one strain of HPV, resulting to a prevalence rate of 50-80% among sexually active adolescents. This ranks HPV infections among the most commonly diagnosed sexually transmitted diseases (STDs) in the US (Faridi, Zahra, Khan, & Idrees, 2011; Gerend & Shepherd, 2012). According to (Gerend & Shepherd, 2012)), an estimated 12,000 cases of invasive cervical cancer, and 4,000 resulting deaths occur in the US annually due to low HPV vaccine uptake, thus predisposing sexually active adolescents to HPV infection (Baseman & Koutsky, 2005; Trottier & Franco, 2006). HPV vaccines have been shown to be safe and effective in preventing genital warts, and cancers of the anogenital tract, yet parental consent to vaccinate is still very low. The low vaccination rate can be attributed to vaccine safety concerns, “license” for adolescents to engage in sexual intercourse, lack of knowledge among the US population about HPV as a cause of genital warts and cancer, its mode of transmission, cost, and missed opportunities by HCPs to either recommend or administer the vaccine to adolescents (Dempsey & Zimet, 2008; Faridi et al., 2011). A child’s HCP is consistently cited as the determining factor in parental vaccine

It is estimated that 79 million Americans are currently infected with a strand of Human Papillomavirus (HPV), and that 14 million Americans become infected annually (CDC HPV Questions and Answers, 2016). Human Papillomavirus can cause penile cancer in men, cancer of the vulva, vagina or cervix in females, and esophageal, oropharyngeal, and anal cancers in both men and women (CDC HPV Questions and Answers, 2016). Consequently, 27 million Americans annually are diagnosed with cancer from HPV (CD11.7C What Is HPV, 2016). The morbidity and mortality rates for cervical cancer caused by HPV in the United States are 8.1 and 2.4 per 100,000 respectively; worldwide, the cervical cancer mortality rate is

Cervical cancer is one of the leading causes of cancer related mortality in countries such as India accounting for more than 17% of all cancer deaths in women aged 30-69. [3] Cervical cancer is one such type of cancer in which screening plays a significant role. Clinical trials done in below poverty level populations do encounter ethical issues to a certain extent with regards to informed consent as most or all of these patients are illiterate. However informed consent is extremely important when justifying data for such clinical trials. Countries such as US have implemented Pap smear screening as one of the most important cervical cancer screening methods. In countries as densely populated as India where proper healthcare facilities does not reach slums and extremely poverty stricken societies, alternatives for screening are indicated- VIA or Visual inspection with acetic acid